loadpatents
Patent applications and USPTO patent grants for Dickman; Daniel A.The latest application filed is for "crystalline pharmaceutical".
Patent | Date |
---|---|
Methods and devices for using isoperillyl alcohol Grant 9,211,269 - Chen , et al. December 15, 2 | 2015-12-15 |
Factor VIIa inhibitor Grant 9,181,280 - Dickman , et al. November 10, 2 | 2015-11-10 |
Crystalline Pharmaceutical App 20140303369 - Dickman; Daniel A. ;   et al. | 2014-10-09 |
Factor Viia Inhibitor App 20140221667 - DICKMAN; Daniel A. ;   et al. | 2014-08-07 |
Crystalline pharmaceutical Grant 8,796,451 - Dickman , et al. August 5, 2 | 2014-08-05 |
Factor VIIa inhibitor Grant 8,729,117 - Dickman , et al. May 20, 2 | 2014-05-20 |
Factor Viia Inhibitor App 20140080879 - Dickman; Daniel A. ;   et al. | 2014-03-20 |
Human ADAM-10 inhibitors Grant 8,426,415 - Naganathan , et al. April 23, 2 | 2013-04-23 |
Factor VIIa inhibitor Grant 8,415,328 - Dickman , et al. April 9, 2 | 2013-04-09 |
Crystalline Pharmaceutical App 20110281900 - Dickman; Daniel A. ;   et al. | 2011-11-17 |
Crystalline pharmaceutical Grant 8,058,433 - Dickman , et al. November 15, 2 | 2011-11-15 |
Factor Viia Inhibitor App 20110207939 - Dickman; Daniel A. ;   et al. | 2011-08-25 |
Biaryl carboxylic acid apoptosis promoters Grant 7,989,656 - Wendt , et al. August 2, 2 | 2011-08-02 |
Retroviral protease inhibiting compounds Grant 7,968,707 - Sham , et al. June 28, 2 | 2011-06-28 |
Apoptosis Promoters App 20100234456 - Wendt; Michael D. ;   et al. | 2010-09-16 |
N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2 | 2010-07-13 |
Apoptosis promoters Grant 7,750,004 - Wendt , et al. July 6, 2 | 2010-07-06 |
N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ;   et al. | 2009-05-28 |
N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2 | 2009-03-17 |
Factor Viia Inhibitor App 20080275250 - Dickman; Daniel A. ;   et al. | 2008-11-06 |
Retroviral Protease Inhibiting Compounds App 20080139811 - Sham; Hing Leung ;   et al. | 2008-06-12 |
Retroviral protease inhibiting compounds Grant 7,279,582 - Stoner , et al. October 9, 2 | 2007-10-09 |
Apoptosis promoters App 20070135392 - Wendt; Michael D. ;   et al. | 2007-06-14 |
Crystalline pharmaceutical App 20070027172 - Dickman; Daniel A. ;   et al. | 2007-02-01 |
Crystalline pharmaceutical App 20050124810 - Dickman, Daniel A. ;   et al. | 2005-06-09 |
Crystalline pharmaceutical Grant 6,864,369 - Dickman , et al. March 8, 2 | 2005-03-08 |
N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ;   et al. | 2004-09-30 |
N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2 | 2004-04-13 |
Crystalline pharmaceutical App 20030191313 - Dickman, Daniel A. ;   et al. | 2003-10-09 |
Crystalline pharmaceutical Grant 6,608,198 - Dickman , et al. August 19, 2 | 2003-08-19 |
Retroviral protease inhibiting compounds App 20030100755 - Sham, Hing Leung ;   et al. | 2003-05-29 |
Retroviral protease inhibiting compounds Grant 6,472,529 - Sham , et al. October 29, 2 | 2002-10-29 |
N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ;   et al. | 2002-07-04 |
N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ;   et al. | 2002-05-09 |
Retroviral protease inhibiting compounds App 20020004503 - Sham, Hing Leung ;   et al. | 2002-01-10 |
Crystalline pharmaceutical App 20010051721 - Dickman, Daniel A. ;   et al. | 2001-12-13 |
SEC | 0001285887 | DICKMAN DANIEL A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.